Global Regenerative Medicine Market 2025-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	225 Pages	TechNavio	March, 2025	INF19848587

Best Price Guarantee
Price	from $2,500
Length	225 Pages
Publisher	TechNavio
Published Date	March, 2025
SKU	INF19848587

Regenerative Medicine Market 2025-2029

The regenerative medicine market is forecasted to grow by USD 125827 million during 2024-2029, accelerating at a CAGR of 28.1% during the forecast period. The report on the regenerative medicine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, increasing support from public and private healthcare organizations, and increasing adoption of STEM cell therapy.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's regenerative medicine market is segmented as below:

By Application

Oncology
Musculoskeletal
Dermatology
Others

By Technology

Cell and tissue-based
Gene therapy

By End-user

Hospitals
Clinics
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing number of clinical trials as one of the prime reasons driving the regenerative medicine market growth during the next few years. Also, technological advances associated with regenerative medicine and increasing prominence of chimeric antigen receptor T-cell therapies will lead to sizable demand in the market.

The report on the regenerative medicine market covers the following areas:

Regenerative Medicine Market sizing
Regenerative Medicine Market forecast
Regenerative Medicine Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading regenerative medicine market vendors that include AbbVie Inc., Amgen Inc., Baxter International Inc., Becton Dickinson and Co., Cook Group Inc., F. Hoffmann La Roche Ltd., Integra LifeSciences Holdings Corp., Johnson and Johnson, Medtronic PLC, Merck and Co. Inc., MiMedx Group Inc., Novartis AG, NuVasive Inc., Organogenesis Holdings Inc., Smith and Nephew PLC, Thermo Fisher Scientific Inc., Vericel Corp., and Zimmer Biomet Holdings Inc.. Also, the regenerative medicine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Application; Executive Summary - Chart on Market Segmentation by Technology; Executive Summary - Chart on Market Segmentation by End-user; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on Global - Market size and forecast 2024-2029 ($ million); Data Table on Global - Market size and forecast 2024-2029 ($ million); Chart on Global Market: Year-over-year growth 2024-2029 (%); Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Global Regenerative Medicine Market 2019 - 2023; Historic Market Size - Data Table on Global Regenerative Medicine Market 2019 - 2023 ($ million); 5.2 Application segment analysis 2019 - 2023; Historic Market Size - Application Segment 2019 - 2023 ($ million); 5.3 Technology segment analysis 2019 - 2023; Historic Market Size - Technology Segment 2019 - 2023 ($ million); 5.4 End-user segment analysis 2019 - 2023; Historic Market Size - End-user Segment 2019 - 2023 ($ million); 5.5 Geography segment analysis 2019 - 2023; Historic Market Size - Geography Segment 2019 - 2023 ($ million); 5.6 Country segment analysis 2019 - 2023; Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis: 6.1 Impact of AI on Global Regenerative Medicine Market
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Application: 8.1 Market segments; Chart on Application - Market share 2024-2029 (%); Data Table on Application - Market share 2024-2029 (%); 8.2 Comparison by Application; Chart on Comparison by Application; Data Table on Comparison by Application; 8.3 Oncology - Market size and forecast 2024-2029; Chart on Oncology - Market size and forecast 2024-2029 ($ million); Data Table on Oncology - Market size and forecast 2024-2029 ($ million); Chart on Oncology - Year-over-year growth 2024-2029 (%); Data Table on Oncology - Year-over-year growth 2024-2029 (%); 8.4 Musculoskeletal - Market size and forecast 2024-2029; Chart on Musculoskeletal - Market size and forecast 2024-2029 ($ million); Data Table on Musculoskeletal - Market size and forecast 2024-2029 ($ million); Chart on Musculoskeletal - Year-over-year growth 2024-2029 (%); Data Table on Musculoskeletal - Year-over-year growth 2024-2029 (%); 8.5 Dermatology - Market size and forecast 2024-2029; Chart on Dermatology - Market size and forecast 2024-2029 ($ million); Data Table on Dermatology - Market size and forecast 2024-2029 ($ million); Chart on Dermatology - Year-over-year growth 2024-2029 (%); Data Table on Dermatology - Year-over-year growth 2024-2029 (%); 8.6 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ million); Data Table on Others - Market size and forecast 2024-2029 ($ million); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 8.7 Market opportunity by Application; Market opportunity by Application ($ million); Data Table on Market opportunity by Application ($ million)
9 Market Segmentation by Technology: 9.1 Market segments; Chart on Technology - Market share 2024-2029 (%); Data Table on Technology - Market share 2024-2029 (%); 9.2 Comparison by Technology; Chart on Comparison by Technology; Data Table on Comparison by Technology; 9.3 Cell and tissue-based - Market size and forecast 2024-2029; Chart on Cell and tissue-based - Market size and forecast 2024-2029 ($ million); Data Table on Cell and tissue-based - Market size and forecast 2024-2029 ($ million); Chart on Cell and tissue-based - Year-over-year growth 2024-2029 (%); Data Table on Cell and tissue-based - Year-over-year growth 2024-2029 (%); 9.4 Gene therapy - Market size and forecast 2024-2029; Chart on Gene therapy - Market size and forecast 2024-2029 ($ million); Data Table on Gene therapy - Market size and forecast 2024-2029 ($ million); Chart on Gene therapy - Year-over-year growth 2024-2029 (%); Data Table on Gene therapy - Year-over-year growth 2024-2029 (%); 9.5 Market opportunity by Technology; Market opportunity by Technology ($ million); Data Table on Market opportunity by Technology ($ million)
10 Market Segmentation by End-user: 10.1 Market segments; Chart on End-user - Market share 2024-2029 (%); Data Table on End-user - Market share 2024-2029 (%); 10.2 Comparison by End-user; Chart on Comparison by End-user; Data Table on Comparison by End-user; 10.3 Hospitals - Market size and forecast 2024-2029; Chart on Hospitals - Market size and forecast 2024-2029 ($ million); Data Table on Hospitals - Market size and forecast 2024-2029 ($ million); Chart on Hospitals - Year-over-year growth 2024-2029 (%); Data Table on Hospitals - Year-over-year growth 2024-2029 (%); 10.4 Clinics - Market size and forecast 2024-2029; Chart on Clinics - Market size and forecast 2024-2029 ($ million); Data Table on Clinics - Market size and forecast 2024-2029 ($ million); Chart on Clinics - Year-over-year growth 2024-2029 (%); Data Table on Clinics - Year-over-year growth 2024-2029 (%); 10.5 Others - Market size and forecast 2024-2029; Chart on Others - Market size and forecast 2024-2029 ($ million); Data Table on Others - Market size and forecast 2024-2029 ($ million); Chart on Others - Year-over-year growth 2024-2029 (%); Data Table on Others - Year-over-year growth 2024-2029 (%); 10.6 Market opportunity by End-user; Market opportunity by End-user ($ million); Data Table on Market opportunity by End-user ($ million)
11 Customer Landscape: 11.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape: 12.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2024-2029 (%); Data Table on Market share By Geographical Landscape 2024-2029 (%); 12.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 12.3 North America - Market size and forecast 2024-2029; Chart on North America - Market size and forecast 2024-2029 ($ million); Data Table on North America - Market size and forecast 2024-2029 ($ million); Chart on North America - Year-over-year growth 2024-2029 (%); Data Table on North America - Year-over-year growth 2024-2029 (%); 12.4 Europe - Market size and forecast 2024-2029; Chart on Europe - Market size and forecast 2024-2029 ($ million); Data Table on Europe - Market size and forecast 2024-2029 ($ million); Chart on Europe - Year-over-year growth 2024-2029 (%); Data Table on Europe - Year-over-year growth 2024-2029 (%); 12.5 Asia - Market size and forecast 2024-2029; Chart on Asia - Market size and forecast 2024-2029 ($ million); Data Table on Asia - Market size and forecast 2024-2029 ($ million); Chart on Asia - Year-over-year growth 2024-2029 (%); Data Table on Asia - Year-over-year growth 2024-2029 (%); 12.6 Rest of World (ROW) - Market size and forecast 2024-2029; Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); 12.7 US - Market size and forecast 2024-2029; Chart on US - Market size and forecast 2024-2029 ($ million); Data Table on US - Market size and forecast 2024-2029 ($ million); Chart on US - Year-over-year growth 2024-2029 (%); Data Table on US - Year-over-year growth 2024-2029 (%); 12.8 Germany - Market size and forecast 2024-2029; Chart on Germany - Market size and forecast 2024-2029 ($ million); Data Table on Germany - Market size and forecast 2024-2029 ($ million); Chart on Germany - Year-over-year growth 2024-2029 (%); Data Table on Germany - Year-over-year growth 2024-2029 (%); 12.9 Canada - Market size and forecast 2024-2029; Chart on Canada - Market size and forecast 2024-2029 ($ million); Data Table on Canada - Market size and forecast 2024-2029 ($ million); Chart on Canada - Year-over-year growth 2024-2029 (%); Data Table on Canada - Year-over-year growth 2024-2029 (%); 12.10 Japan - Market size and forecast 2024-2029; Chart on Japan - Market size and forecast 2024-2029 ($ million); Data Table on Japan - Market size and forecast 2024-2029 ($ million); Chart on Japan - Year-over-year growth 2024-2029 (%); Data Table on Japan - Year-over-year growth 2024-2029 (%); 12.11 China - Market size and forecast 2024-2029; Chart on China - Market size and forecast 2024-2029 ($ million); Data Table on China - Market size and forecast 2024-2029 ($ million); Chart on China - Year-over-year growth 2024-2029 (%); Data Table on China - Year-over-year growth 2024-2029 (%); 12.12 UK - Market size and forecast 2024-2029; Chart on UK - Market size and forecast 2024-2029 ($ million); Data Table on UK - Market size and forecast 2024-2029 ($ million); Chart on UK - Year-over-year growth 2024-2029 (%); Data Table on UK - Year-over-year growth 2024-2029 (%); 12.13 France - Market size and forecast 2024-2029; Chart on France - Market size and forecast 2024-2029 ($ million); Data Table on France - Market size and forecast 2024-2029 ($ million); Chart on France - Year-over-year growth 2024-2029 (%); Data Table on France - Year-over-year growth 2024-2029 (%); 12.14 South Korea - Market size and forecast 2024-2029; Chart on South Korea - Market size and forecast 2024-2029 ($ million); Data Table on South Korea - Market size and forecast 2024-2029 ($ million); Chart on South Korea - Year-over-year growth 2024-2029 (%); Data Table on South Korea - Year-over-year growth 2024-2029 (%); 12.15 The Netherlands - Market size and forecast 2024-2029; Chart on The Netherlands - Market size and forecast 2024-2029 ($ million); Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million); Chart on The Netherlands - Year-over-year growth 2024-2029 (%); Data Table on The Netherlands - Year-over-year growth 2024-2029 (%); 12.16 Brazil - Market size and forecast 2024-2029; Chart on Brazil - Market size and forecast 2024-2029 ($ million); Data Table on Brazil - Market size and forecast 2024-2029 ($ million); Chart on Brazil - Year-over-year growth 2024-2029 (%); Data Table on Brazil - Year-over-year growth 2024-2029 (%); 12.17 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ million); Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints: 13.1 Market drivers; 13.2 Market challenges; 13.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 13.4 Market opportunities/restraints
14 Competitive Landscape: 14.1 Overview; 14.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 14.3 Landscape disruption; Overview on factors of disruption; 14.4 Industry risks; Impact of key risks on business
15 Competitive Analysis: 15.1 Companies profiled; Companies covered; 15.2 Company ranking index; Company ranking index; 15.3 Market positioning of companies; Matrix on companies position and classification; 15.4 AbbVie Inc.; AbbVie Inc. - Overview; AbbVie Inc. - Product / Service; AbbVie Inc. - Key news; AbbVie Inc. - Key offerings; SWOT; 15.5 Amgen Inc.; Amgen Inc. - Overview; Amgen Inc. - Product / Service; Amgen Inc. - Key news; Amgen Inc. - Key offerings; SWOT; 15.6 Baxter International Inc.; Baxter International Inc. - Overview; Baxter International Inc. - Business segments; Baxter International Inc. - Key news; Baxter International Inc. - Key offerings; Baxter International Inc. - Segment focus; SWOT; 15.7 Becton Dickinson and Co.; Becton Dickinson and Co. - Overview; Becton Dickinson and Co. - Business segments; Becton Dickinson and Co. - Key news; Becton Dickinson and Co. - Key offerings; Becton Dickinson and Co. - Segment focus; SWOT; 15.8 Cook Group Inc.; Cook Group Inc. - Overview; Cook Group Inc. - Product / Service; Cook Group Inc. - Key news; Cook Group Inc. - Key offerings; SWOT; 15.9 Integra LifeSciences Holdings Corp.; Integra LifeSciences Holdings Corp. - Overview; Integra LifeSciences Holdings Corp. - Business segments; Integra LifeSciences Holdings Corp. - Key news; Integra LifeSciences Holdings Corp. - Key offerings; Integra LifeSciences Holdings Corp. - Segment focus; SWOT; 15.10 Medtronic Plc; Medtronic Plc - Overview; Medtronic Plc - Business segments; Medtronic Plc - Key news; Medtronic Plc - Key offerings; Medtronic Plc - Segment focus; SWOT; 15.11 Merck and Co. Inc.; Merck and Co. Inc. - Overview; Merck and Co. Inc. - Business segments; Merck and Co. Inc. - Key news; Merck and Co. Inc. - Key offerings; Merck and Co. Inc. - Segment focus; SWOT; 15.12 MiMedx Group Inc.; MiMedx Group Inc. - Overview; MiMedx Group Inc. - Business segments; MiMedx Group Inc. - Key offerings; MiMedx Group Inc. - Segment focus; SWOT; 15.13 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; SWOT; 15.14 NuVasive Inc.; NuVasive Inc. - Overview; NuVasive Inc. - Business segments; NuVasive Inc. - Key offerings; NuVasive Inc. - Segment focus; SWOT; 15.15 Organogenesis Holdings Inc.; Organogenesis Holdings Inc. - Overview; Organogenesis Holdings Inc. - Product / Service; Organogenesis Holdings Inc. - Key offerings; SWOT; 15.16 Smith and Nephew plc; Smith and Nephew plc - Overview; Smith and Nephew plc - Business segments; Smith and Nephew plc - Key news; Smith and Nephew plc - Key offerings; Smith and Nephew plc - Segment focus; SWOT; 15.17 Thermo Fisher Scientific Inc.; Thermo Fisher Scientific Inc. - Overview; Thermo Fisher Scientific Inc. - Business segments; Thermo Fisher Scientific Inc. - Key news; Thermo Fisher Scientific Inc. - Key offerings; Thermo Fisher Scientific Inc. - Segment focus; SWOT; 15.18 Vericel Corp.; Vericel Corp. - Overview; Vericel Corp. - Product / Service; Vericel Corp. - Key offerings; SWOT
16 Appendix: 16.1 Scope of the report; 16.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 16.3 Currency conversion rates for US$; Currency conversion rates for US$; 16.4 Research methodology; Research methodology; 16.5 Data procurement; Information sources; 16.6 Data validation; Data validation; 16.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 16.8 Data synthesis; Data synthesis; 16.9 360 degree market analysis; 360 degree market analysis; 16.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Application; Exhibits6: Executive Summary - Chart on Market Segmentation by Technology; Exhibits7: Executive Summary - Chart on Market Segmentation by End-user; Exhibits8: Executive Summary - Chart on Incremental Growth; Exhibits9: Executive Summary - Data Table on Incremental Growth; Exhibits10: Executive Summary - Chart on Company Market Positioning; Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits12: Overview on criticality of inputs and factors of differentiation; Exhibits13: Overview on factors of disruption; Exhibits14: Impact of drivers and challenges in 2024 and 2029; Exhibits15: Parent Market; Exhibits16: Data Table on - Parent Market; Exhibits17: Market characteristics analysis; Exhibits18: Value chain analysis; Exhibits19: Offerings of companies included in the market definition; Exhibits20: Market segments; Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million); Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million); Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%); Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%); Exhibits25: Historic Market Size - Data Table on Global Regenerative Medicine Market 2019 - 2023 ($ million); Exhibits26: Historic Market Size - Application Segment 2019 - 2023 ($ million); Exhibits27: Historic Market Size - Technology Segment 2019 - 2023 ($ million); Exhibits28: Historic Market Size - End-user Segment 2019 - 2023 ($ million); Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million); Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million); Exhibits31: Five forces analysis - Comparison between 2024 and 2029; Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits37: Chart on Market condition - Five forces 2024 and 2029; Exhibits38: Chart on Application - Market share 2024-2029 (%); Exhibits39: Data Table on Application - Market share 2024-2029 (%); Exhibits40: Chart on Comparison by Application; Exhibits41: Data Table on Comparison by Application; Exhibits42: Chart on Oncology - Market size and forecast 2024-2029 ($ million); Exhibits43: Data Table on Oncology - Market size and forecast 2024-2029 ($ million); Exhibits44: Chart on Oncology - Year-over-year growth 2024-2029 (%); Exhibits45: Data Table on Oncology - Year-over-year growth 2024-2029 (%); Exhibits46: Chart on Musculoskeletal - Market size and forecast 2024-2029 ($ million); Exhibits47: Data Table on Musculoskeletal - Market size and forecast 2024-2029 ($ million); Exhibits48: Chart on Musculoskeletal - Year-over-year growth 2024-2029 (%); Exhibits49: Data Table on Musculoskeletal - Year-over-year growth 2024-2029 (%); Exhibits50: Chart on Dermatology - Market size and forecast 2024-2029 ($ million); Exhibits51: Data Table on Dermatology - Market size and forecast 2024-2029 ($ million); Exhibits52: Chart on Dermatology - Year-over-year growth 2024-2029 (%); Exhibits53: Data Table on Dermatology - Year-over-year growth 2024-2029 (%); Exhibits54: Chart on Others - Market size and forecast 2024-2029 ($ million); Exhibits55: Data Table on Others - Market size and forecast 2024-2029 ($ million); Exhibits56: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits57: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits58: Market opportunity by Application ($ million); Exhibits59: Data Table on Market opportunity by Application ($ million); Exhibits60: Chart on Technology - Market share 2024-2029 (%); Exhibits61: Data Table on Technology - Market share 2024-2029 (%); Exhibits62: Chart on Comparison by Technology; Exhibits63: Data Table on Comparison by Technology; Exhibits64: Chart on Cell and tissue-based - Market size and forecast 2024-2029 ($ million); Exhibits65: Data Table on Cell and tissue-based - Market size and forecast 2024-2029 ($ million); Exhibits66: Chart on Cell and tissue-based - Year-over-year growth 2024-2029 (%); Exhibits67: Data Table on Cell and tissue-based - Year-over-year growth 2024-2029 (%); Exhibits68: Chart on Gene therapy - Market size and forecast 2024-2029 ($ million); Exhibits69: Data Table on Gene therapy - Market size and forecast 2024-2029 ($ million); Exhibits70: Chart on Gene therapy - Year-over-year growth 2024-2029 (%); Exhibits71: Data Table on Gene therapy - Year-over-year growth 2024-2029 (%); Exhibits72: Market opportunity by Technology ($ million); Exhibits73: Data Table on Market opportunity by Technology ($ million); Exhibits74: Chart on End-user - Market share 2024-2029 (%); Exhibits75: Data Table on End-user - Market share 2024-2029 (%); Exhibits76: Chart on Comparison by End-user; Exhibits77: Data Table on Comparison by End-user; Exhibits78: Chart on Hospitals - Market size and forecast 2024-2029 ($ million); Exhibits79: Data Table on Hospitals - Market size and forecast 2024-2029 ($ million); Exhibits80: Chart on Hospitals - Year-over-year growth 2024-2029 (%); Exhibits81: Data Table on Hospitals - Year-over-year growth 2024-2029 (%); Exhibits82: Chart on Clinics - Market size and forecast 2024-2029 ($ million); Exhibits83: Data Table on Clinics - Market size and forecast 2024-2029 ($ million); Exhibits84: Chart on Clinics - Year-over-year growth 2024-2029 (%); Exhibits85: Data Table on Clinics - Year-over-year growth 2024-2029 (%); Exhibits86: Chart on Others - Market size and forecast 2024-2029 ($ million); Exhibits87: Data Table on Others - Market size and forecast 2024-2029 ($ million); Exhibits88: Chart on Others - Year-over-year growth 2024-2029 (%); Exhibits89: Data Table on Others - Year-over-year growth 2024-2029 (%); Exhibits90: Market opportunity by End-user ($ million); Exhibits91: Data Table on Market opportunity by End-user ($ million); Exhibits92: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits93: Chart on Market share By Geographical Landscape 2024-2029 (%); Exhibits94: Data Table on Market share By Geographical Landscape 2024-2029 (%); Exhibits95: Chart on Geographic comparison; Exhibits96: Data Table on Geographic comparison; Exhibits97: Chart on North America - Market size and forecast 2024-2029 ($ million); Exhibits98: Data Table on North America - Market size and forecast 2024-2029 ($ million); Exhibits99: Chart on North America - Year-over-year growth 2024-2029 (%); Exhibits100: Data Table on North America - Year-over-year growth 2024-2029 (%); Exhibits101: Chart on Europe - Market size and forecast 2024-2029 ($ million); Exhibits102: Data Table on Europe - Market size and forecast 2024-2029 ($ million); Exhibits103: Chart on Europe - Year-over-year growth 2024-2029 (%); Exhibits104: Data Table on Europe - Year-over-year growth 2024-2029 (%); Exhibits105: Chart on Asia - Market size and forecast 2024-2029 ($ million); Exhibits106: Data Table on Asia - Market size and forecast 2024-2029 ($ million); Exhibits107: Chart on Asia - Year-over-year growth 2024-2029 (%); Exhibits108: Data Table on Asia - Year-over-year growth 2024-2029 (%); Exhibits109: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Exhibits110: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million); Exhibits111: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits112: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits113: Chart on US - Market size and forecast 2024-2029 ($ million); Exhibits114: Data Table on US - Market size and forecast 2024-2029 ($ million); Exhibits115: Chart on US - Year-over-year growth 2024-2029 (%); Exhibits116: Data Table on US - Year-over-year growth 2024-2029 (%); Exhibits117: Chart on Germany - Market size and forecast 2024-2029 ($ million); Exhibits118: Data Table on Germany - Market size and forecast 2024-2029 ($ million); Exhibits119: Chart on Germany - Year-over-year growth 2024-2029 (%); Exhibits120: Data Table on Germany - Year-over-year growth 2024-2029 (%); Exhibits121: Chart on Canada - Market size and forecast 2024-2029 ($ million); Exhibits122: Data Table on Canada - Market size and forecast 2024-2029 ($ million); Exhibits123: Chart on Canada - Year-over-year growth 2024-2029 (%); Exhibits124: Data Table on Canada - Year-over-year growth 2024-2029 (%); Exhibits125: Chart on Japan - Market size and forecast 2024-2029 ($ million); Exhibits126: Data Table on Japan - Market size and forecast 2024-2029 ($ million); Exhibits127: Chart on Japan - Year-over-year growth 2024-2029 (%); Exhibits128: Data Table on Japan - Year-over-year growth 2024-2029 (%); Exhibits129: Chart on China - Market size and forecast 2024-2029 ($ million); Exhibits130: Data Table on China - Market size and forecast 2024-2029 ($ million); Exhibits131: Chart on China - Year-over-year growth 2024-2029 (%); Exhibits132: Data Table on China - Year-over-year growth 2024-2029 (%); Exhibits133: Chart on UK - Market size and forecast 2024-2029 ($ million); Exhibits134: Data Table on UK - Market size and forecast 2024-2029 ($ million); Exhibits135: Chart on UK - Year-over-year growth 2024-2029 (%); Exhibits136: Data Table on UK - Year-over-year growth 2024-2029 (%); Exhibits137: Chart on France - Market size and forecast 2024-2029 ($ million); Exhibits138: Data Table on France - Market size and forecast 2024-2029 ($ million); Exhibits139: Chart on France - Year-over-year growth 2024-2029 (%); Exhibits140: Data Table on France - Year-over-year growth 2024-2029 (%); Exhibits141: Chart on South Korea - Market size and forecast 2024-2029 ($ million); Exhibits142: Data Table on South Korea - Market size and forecast 2024-2029 ($ million); Exhibits143: Chart on South Korea - Year-over-year growth 2024-2029 (%); Exhibits144: Data Table on South Korea - Year-over-year growth 2024-2029 (%); Exhibits145: Chart on The Netherlands - Market size and forecast 2024-2029 ($ million); Exhibits146: Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million); Exhibits147: Chart on The Netherlands - Year-over-year growth 2024-2029 (%); Exhibits148: Data Table on The Netherlands - Year-over-year growth 2024-2029 (%); Exhibits149: Chart on Brazil - Market size and forecast 2024-2029 ($ million); Exhibits150: Data Table on Brazil - Market size and forecast 2024-2029 ($ million); Exhibits151: Chart on Brazil - Year-over-year growth 2024-2029 (%); Exhibits152: Data Table on Brazil - Year-over-year growth 2024-2029 (%); Exhibits153: Market opportunity By Geographical Landscape ($ million); Exhibits154: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits155: Impact of drivers and challenges in 2024 and 2029; Exhibits156: Overview on criticality of inputs and factors of differentiation; Exhibits157: Overview on factors of disruption; Exhibits158: Impact of key risks on business; Exhibits159: Companies covered; Exhibits160: Company ranking index; Exhibits161: Matrix on companies position and classification; Exhibits162: AbbVie Inc. - Overview; Exhibits163: AbbVie Inc. - Product / Service; Exhibits164: AbbVie Inc. - Key news; Exhibits165: AbbVie Inc. - Key offerings; Exhibits166: SWOT; Exhibits167: Amgen Inc. - Overview; Exhibits168: Amgen Inc. - Product / Service; Exhibits169: Amgen Inc. - Key news; Exhibits170: Amgen Inc. - Key offerings; Exhibits171: SWOT; Exhibits172: Baxter International Inc. - Overview; Exhibits173: Baxter International Inc. - Business segments; Exhibits174: Baxter International Inc. - Key news; Exhibits175: Baxter International Inc. - Key offerings; Exhibits176: Baxter International Inc. - Segment focus; Exhibits177: SWOT; Exhibits178: Becton Dickinson and Co. - Overview; Exhibits179: Becton Dickinson and Co. - Business segments; Exhibits180: Becton Dickinson and Co. - Key news; Exhibits181: Becton Dickinson and Co. - Key offerings; Exhibits182: Becton Dickinson and Co. - Segment focus; Exhibits183: SWOT; Exhibits184: Cook Group Inc. - Overview; Exhibits185: Cook Group Inc. - Product / Service; Exhibits186: Cook Group Inc. - Key news; Exhibits187: Cook Group Inc. - Key offerings; Exhibits188: SWOT; Exhibits189: Integra LifeSciences Holdings Corp. - Overview; Exhibits190: Integra LifeSciences Holdings Corp. - Business segments; Exhibits191: Integra LifeSciences Holdings Corp. - Key news; Exhibits192: Integra LifeSciences Holdings Corp. - Key offerings; Exhibits193: Integra LifeSciences Holdings Corp. - Segment focus; Exhibits194: SWOT; Exhibits195: Medtronic Plc - Overview; Exhibits196: Medtronic Plc - Business segments; Exhibits197: Medtronic Plc - Key news; Exhibits198: Medtronic Plc - Key offerings; Exhibits199: Medtronic Plc - Segment focus; Exhibits200: SWOT; Exhibits201: Merck and Co. Inc. - Overview; Exhibits202: Merck and Co. Inc. - Business segments; Exhibits203: Merck and Co. Inc. - Key news; Exhibits204: Merck and Co. Inc. - Key offerings; Exhibits205: Merck and Co. Inc. - Segment focus; Exhibits206: SWOT; Exhibits207: MiMedx Group Inc. - Overview; Exhibits208: MiMedx Group Inc. - Business segments; Exhibits209: MiMedx Group Inc. - Key offerings; Exhibits210: MiMedx Group Inc. - Segment focus; Exhibits211: SWOT; Exhibits212: Novartis AG - Overview; Exhibits213: Novartis AG - Business segments; Exhibits214: Novartis AG - Key news; Exhibits215: Novartis AG - Key offerings; Exhibits216: Novartis AG - Segment focus; Exhibits217: SWOT; Exhibits218: NuVasive Inc. - Overview; Exhibits219: NuVasive Inc. - Business segments; Exhibits220: NuVasive Inc. - Key offerings; Exhibits221: NuVasive Inc. - Segment focus; Exhibits222: SWOT; Exhibits223: Organogenesis Holdings Inc. - Overview; Exhibits224: Organogenesis Holdings Inc. - Product / Service; Exhibits225: Organogenesis Holdings Inc. - Key offerings; Exhibits226: SWOT; Exhibits227: Smith and Nephew plc - Overview; Exhibits228: Smith and Nephew plc - Business segments; Exhibits229: Smith and Nephew plc - Key news; Exhibits230: Smith and Nephew plc - Key offerings; Exhi